Search Results

A Post-Authorization Safety Study (PASS) to Assess Long-term Safety in Patients with Pompe Disease Treated with Avalglucosidase alfa in the Real-World Setting: the SAVANT (Safety assessment of AValglucosidase Alfa as a Novel Treatment) study-STUDY00005276

To collect long term safety data and evaluate the important identified risk of infusion associated reactions (IARs) including hypersensitivity and...

A Phase 3, Prospective, Open-Label, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Paricalcitol Oral Solution for the Treatment of Secondary Hyperparathyroidism in Pediatric Subjects Ages 0 to 9 Years with Stage 5-STUDY00002090

THis Phase 3 multi center study will evaluate the safety, efficacy and pharmacokinetics of paricalcitol oral solution for the treatment of...

A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function in Infants and Young Children (BEGIN)-STUDY00002933

This two-part, multi-center, prospective longitudinal, exploratory study of highly effective cystic fibrosis transmembrane conductance regulator...

Limitations of Resuscitation in Pediatric Patients

Limitations of Resuscitation in Pediatric Patients

Brain Tumor Resource Lab

Brain Tumor Resource Lab The Brain Tumor Resource Lab strives to generate and distribute patient-derived xenograft models and cell lines. Our focus...

Health Information and Visualization Experience (HIVE) Lab Team

Health Information and Visualization Experience (HIVE) Lab Team, Center for Clinical and Translational Research, Seattle Children's Research...

Feature Story CCTR

CCTR: Feature Story

Spotlight on Pulmonary Research

CCTR News: Spotlight on Pulmonary Research

Selected Publications - Stuart Lab - Seattle Children's

See a list of Dr. Ken Stuart’s publications.

Lab Team: Urdahl Lab

Meet the Urdahl Lab team.